Target intelligence / Profile preview

Transmembrane protein 19 (TMEM19)

Target
TMEM19
Molecular classification
Other (specifically "Protein of unknown function DUF92, TMEM19" based on InterPro classification[3][5])
01

Overview

Transmembrane protein 19 (TMEM19) is a protein in humans encoded by the TMEM19 gene, located on chromosome 12q21.1[1][5]. The protein comprises 336 amino acids and features 6 transmembrane regions, with moderate expression in various tissues and highest levels reported in superior cervical ganglia and cardiac myocytes[1][4]. TMEM19 is annotated as a protein of unknown function (DUF92 family) and appears to associate with the cell membrane, with predicted activity based on computational models[3][5]. Associations have been made between TMEM19 genetic loci and non-syndromic cleft lip with palate as well as ammonia nitrogen tolerance, but no clear or direct therapeutic targeting roles or mechanistic disease implications have been established[1]. Protein–protein interaction data suggest TMEM19 interacts with a variety of membrane-associated proteins, but its precise function remains uncharacterized[1]. No known drugs or targeted therapies are reported, and there is no established role as a therapeutic target in the biomedical literature to date[1][3][5].

Other names
TMEM19FLJ10936transmembrane protein 19
02

Biological functions

Other (no well-established functions; predicted to be active in membrane, associations with cell membrane processes, but not clearly linked to canonical biological functions like signal transduction)[1][5][3]
03

Disease associations

Other (gene locus identified as a risk factor in non-syndromic cleft lip with palate; possible involvement in ammonia nitrogen tolerance; indirect role in non-alcoholic fatty liver disease via stress response and cell death; no strong evidence for a major, direct disease association)[1]

Beyond the preview

Go deeper on Transmembrane protein 19 (TMEM19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 19 (TMEM19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call